Alliancebernstein L.P. Sangamo Therapeutics, Inc Transaction History

Alliancebernstein L.P.

$275 Billion
Q1 2024

A detailed history of Alliancebernstein L.P. transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Alliancebernstein L.P. holds 237,830 shares of SGMO stock, worth $85,618. This represents 0.0% of its overall portfolio holdings.

Number of Shares

237,830

Previous 237,830 -0.0%

Holding current value

$85,618

Previous $128,000 24.22%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.3 - $0.63 $4,857 - $10,200	-16,191 Reduced 6.37%	237,830 $128,000
Q2 2023 Aug 15, 2023	BUY	$1.11 - $1.74 $97,624 - $153,033	87,950 Added 52.96%	254,021 $330,000
Q1 2023 May 15, 2023	SELL	$1.66 - $3.67 $308,760 - $682,620	-186,000 Reduced 52.83%	166,071 $292,000
Q4 2022 Feb 14, 2023	BUY	$2.77 - $5.07 $554,000 - $1.01 Million	200,000 Added 131.52%	352,071 $1.11 Million
Q3 2022 Nov 15, 2022	SELL	$4.27 - $6.39 $1.23 Million - $1.84 Million	-287,616 Reduced 65.41%	152,071 $745,000

Q2 2022 Aug 15, 2022	BUY	$3.28 - $6.21 $943,380 - $1.79 Million	287,616 Added 189.13%	439,687 $1.82 Million
Q1 2022 May 13, 2022	BUY	$5.23 - $7.82 $1,569 - $2,346	300 Added 0.2%	152,071 $884,000
Q2 2021 Jul 30, 2021	SELL	$10.17 - $12.64 $47,493 - $59,028	-4,670 Reduced 2.99%	151,771 $1.82 Million
Q1 2021 May 06, 2021	BUY	$10.88 - $17.05 $36,992 - $57,970	3,400 Added 2.22%	156,441 $1.96 Million
Q4 2020 Feb 08, 2021	BUY	$9.23 - $18.18 $255,671 - $503,586	27,700 Added 22.1%	153,041 $2.39 Million
Q3 2020 Nov 12, 2020	SELL	$9.38 - $12.48 $186,662 - $248,352	-19,900 Reduced 13.7%	125,341 $1.18 Million
Q3 2019 Nov 14, 2019	SELL	$9.05 - $12.22 $86,880 - $117,312	-9,600 Reduced 6.2%	145,241 $1.31 Million
Q2 2019 Aug 14, 2019	BUY	$8.75 - $13.03 $103,250 - $153,754	11,800 Added 8.25%	154,841 $1.67 Million
Q2 2018 Aug 13, 2018	SELL	$13.9 - $19.8 $510,991 - $727,887	-36,762 Reduced 20.45%	143,041 $2.03 Million
Q1 2018 May 14, 2018	SELL	$16.7 - $26.35 $180,026 - $284,053	-10,780 Reduced 5.66%	179,803 $3.42 Million
Q3 2017 Nov 13, 2017	BUY	$8.4 - $15.0 $1.6 Million - $2.86 Million	190,583	190,583 $2.86 Million

Others Institutions Holding SGMO

# of Institutions

138

Shares Held

100M

Call Options Held

35.5K

Put Options Held

65.8K

View Full List

About SANGAMO THERAPEUTICS, INC

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $56.4M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

More about SGMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Sangamo Therapeutics, Inc Transaction History